Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303

PURPOSE: Cisplatin or cetuximab combined with radiotherapy (RT) each yield superior survival in locally advanced squamous cell head and neck cancer (LA-SCCHN) compared to RT alone. E3303 evaluated the triple combination. EXPERIMENTAL DESIGN: Patients with stage IV unresectable LA-SCCHN received a lo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Egloff, Ann Marie, Lee, Ju-Whei, Langer, Corey J., Quon, Harry, Vaezi, Alec, Grandis, Jennifer R., Seethala, Raja R., Wang, Lin, Shin, Dong M., Argiris, Athanassios, Yang, Donghua, Mehra, Ranee, Ridge, John Andrew, Patel, Urjeet A., Burtness, Barbara A., Forastiere, Arlene A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4184913/
https://ncbi.nlm.nih.gov/pubmed/25107914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-0051
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados